scPharmaceuticals Inc (SCPH)
4.74
-0.08
(-1.76%)
USD |
NASDAQ |
May 17, 16:00
4.74
0.00 (0.00%)
After-Hours: 20:00
scPharmaceuticals Gross Profit Margin (Quarterly): 70.75% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 70.75% |
December 31, 2023 | 70.92% |
September 30, 2023 | 71.58% |
Date | Value |
---|---|
June 30, 2023 | 78.39% |
March 31, 2023 | 70.67% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
70.67%
Minimum
Mar 2023
78.39%
Maximum
Jun 2023
72.46%
Average
70.92%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
Anika Therapeutics Inc | 60.78% |
Spero Therapeutics Inc | -- |
electroCore Inc | 83.69% |
NovaBay Pharmaceuticals Inc | 68.19% |
Palatin Technologies Inc | 95.20% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -115.3% |
Return on Assets | -55.43% |
Return on Invested Capital | -65.34% |
Profit Margin (Quarterly) | -231.2% |
Operating Margin (Quarterly) | -259.8% |
Return on Net Operating Assets | -411.4% |